Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Xceleron Adds to U.S. Footprint | Contract Pharma

What are you searching for?

Sign in
Breaking News

Xceleron Adds to U.S. Footprint

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Xceleron, a provider of analytical strategies for drug development, will expand its U.S. business by signing of a lease on a facility in Germantown, MD. The facility, opening in November 2007, will house a new accelerator mass spectrometer (AMS) and employ at least 20 people in scientific, commercial and administrative roles.

Professor Colin Garner, Xceleron’s chief executive officer, commented, “This is a major strategic development in the evolution of our company. We will invest as much as $7.5 million on the purchase of a new AMS and associated equipment to carry out analysis on pharmaceutical drug candidates. Our new facility will allow us to substantially increase our development capacity to better serve our customers worldwide.” The company began U.S. operations in 2005.
 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics